Talviraline is a non-nucleoside reverse transcriptase (NNRT) inhibitor primarily used to inhibit the replication of human immunodeficiency virus type 1 (HIV-1). It functions by binding to a specific site on HIV-1 reverse transcriptase (RT), thereby blocking viral replication. Talviraline can be used in potential therapeutic strategies and safety studies for HIV-1 infection.